Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival
<p style="text-align:justify;"> Factor-inhibiting hypoxia-inducible factor (HIF)-1 (FIH-1) is an asparaginyl β-hydroxylase enzyme that was initially found to hydroxylate the HIF-α, preventing its transcriptional activity and leading to adaptive responses to hypoxia. More recently, o...
Prif Awduron: | Kiriakidis, S, Henze, A, Kruszynska-Ziaja, I, Skobridis, K, Theodorou, V, Paleolog, E, Mazzone, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Federation of American Society of Experimental Biology
2015
|
Eitemau Tebyg
-
Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis.
gan: Khan, M, et al.
Cyhoeddwyd: (2011) -
The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.
gan: Enfeng Wang, et al.
Cyhoeddwyd: (2014-01-01) -
Factor inhibiting HIF (FIH1) modulates cardiac function and metabolism
gan: Holliday, J, et al.
Cyhoeddwyd: (2018) -
Investigating the role of factor inhibiting HIF (FIH) in tumourigenesis
gan: Ma, J
Cyhoeddwyd: (2017) -
Factor-inhibiting HIF (FIH) promotes lung cancer progression
gan: Ana García-del Río, et al.
Cyhoeddwyd: (2023-10-01)